Completed
Evaluate Mesothelin as a Biomarker for the Clinical Management of Esophageal Adenocarcinoma (EAC)
NCT01393483
- Conditions
- Adenocarcinoma, Carcinoma, Digestive System Diseases, +11 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States